Fortunately, HLA-G down-regulation with RNA interference or antibody blockade can recover the functions of immune effectors and prevent tumor reoccurrence, raising the possibility that HLA-G/ILTs interaction blockade could be a potential immuno-therapeutic strategy for cancer treatment (32, 39, 40). Here, HLA-G is linked to neoplasm.